Hawthorn Pharmaceuticals, Inc. – Product Pipeline Review – 2012 - This pharmaceuticals report, "Hawthorn Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the Hawthorn Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from our proprietary databases, Hawthorn Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Hawthorn Pharmaceuticals, Inc. and industry-specific third party sources, put together by our team.

Scope

- Hawthorn Pharmaceuticals, Inc. - Brief Hawthorn Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Hawthorn Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Hawthorn Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Hawthorn Pharmaceuticals, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Hawthorn Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Hawthorn Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Hawthorn Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Hawthorn Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Hawthorn Pharmaceuticals, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Hawthorn Pharmaceuticals, Inc.; Hawthorn Pharmaceuticals, Inc. - Key Therapeutics; Hawthorn Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Hawthorn Pharmaceuticals, Inc. - News; Hawthorn Pharmaceuticals, Inc. - Latest Updates; Hawthorn Pharmaceuticals, Inc. - Pipeline; Hawthorn Pharmaceuticals, Inc. - Discontinued/Dormant Projects

Click for Report details:Hawthorn Pharmaceuticals, Inc. - Product Pipeline Review - 2012